Cost effectiveness of pneumococcal vaccination for infants and children with the conjugate vaccine PnC-7 in Germany

PharmacoEconomics

Volumn 21, Issue 8, 2003, Pages 587-600

  Claes, Christa ^a   Graf Von Der Schulenburg, Johann Matthias ^a  

^a LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; PNEUMOCOCCAL HEPTAVALENT CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG CONJUGATION; DRUG COST; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; GERMANY; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INCIDENCE; INFANT; INFANT MORTALITY; MONEY; OUTCOMES RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; VACCINATION;

AGE FACTORS; COST-BENEFIT ANALYSIS; GERMANY; HEALTH CARE COSTS; HUMANS; INFANT; MARKOV CHAINS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PROBABILITY; VACCINES, CONJUGATE;

EID: 0037833496     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200321080-00005     Document Type: Article

References (37)

1. Robert Koch Institut (RKI). Immunisation recommendations of the Standing Committee on Immunisation (STIKO) at Robert Koch-Institut/Stand: Juli 2001. Epidemiol Bull 2001; 28: 203-18
2. Lieu TA, Ray GT, Black SB, et al. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA 2000; 283 (11): 1460-8
3. Hanoveraner Consensus Group. German recommendations regarding to health-economic evaluation: revised version of the Hanoverian Consensus [in German]. Gesundheitsökonomie und Qualitätsmanagement 1999; 4: A62-5
4. Adam D. Pneumococcal illnesses (meningitis, pneumonia, sepsis) in infancy from clinical view [in German]. In: Stück B, Voß H, editors. Pneumococcal illnesses of babies and toddlers [in German]. Marburg: Verlag im Kilian, 2001: 11-14
5. Ziebold C, von Kries R, Siedler A, et al. Epidemiology of pneumococcal disease in children in Germany. Acta Paediatr Suppl 2000; 89 (435): 17-21
6. Rosenblut A, Santolaya ME, Gonzalez P, et al. Bacterial and viral etiology of acute otitis media in Chilean children. Pediatr Infect Dis J 2001; 20 (5): 501-7
7. Von Kries R, Siedler A, Schmitt HJ, et al. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis 2000; 31 (2): 482-7
8. Siedler A. Illnesses by pneumococcus: epidemiological situation in Germany (Emphasis invasive illnesses) [in German]. In: Stück B, Voß H, editors. Pneumococcal illnesses of babies and toddlers [in German]. Marburg: Verlag im Kilian, 2001: 44-53
9. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001; 344 (6): 403-9
10. Von Kries R, Hermann M, Al-Lahham A, et al. Will the 7-valent pneumoccocal vaccine have a similar impact on all invasive pneumococcal infections in children in Germany as in the Kaiser Permanente Trial? Eur J Pediatr 2002; 161 Suppl. 2: S140-3
11. Black SB, Shinefield HR, Ling S, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 2002 Sep; 21 (9): 810-5
12. Müller-Werdan A, Werdan K. Therapy of sepsis - a position reckoning [in German]. Arzneimitteltherapie 1999; 4: 126
13. Schmöle-Thoma B. Efficacy and compatibility of the pneumococcal conjugate vaccines [in German]. In: Stück B, Voß H, editors. Pneumococcal illnesses of babies and toddlers [in German]. Marburg: Verlag im Kilian, 2001: 72-78
14. Homepage of IMS Health [online]. Available from URL: http://www.imshealth.de [Accessed 2003 Jan 30]
15. Adam D, Scholz H. Efficacy of pneumococcal conjugate vaccine in children [in German]. Klinische Padiatrie 2001; 213 (3): 109-13
16. Baraff LJ, Lee SI, Schriger OL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J 1993; 12 (5): 389-94
17. Louvois J de, Bedford H, Peckham C, et al. Epidemiology of infantile meningitis: results from a five-year prospective follow-up of 1721 survivors of meningitis in the first year of life [abstract 12]. 19th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID); 2001 Mar 26-28; Istanbul
18. Statistisches Bundesamt (Federal Statistical Office), editor. Health report for Germany [in German]. Wiesbaden: Metzler-Poeschel, 1998: 235
19. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children: Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000; 19: 187-95
20. Von Kries R, Hermann M, Hachmeister A, et al. Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children. Pediatr Infect Dis J 2002; 21 (1): 1017-23
21. Fireman B, Black SB, Shinefield HR, et al. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 2003; 22 (1): 10-6
22. Wenzel RP. Antiendotoxin monoclonal antibodies: a second look. N Engl J Med 1992; 326: 1151-2
23. Zok K. Hearing aids in competition. Channels of supply in comparison [in German]. Bonn: Research Institute of the Local Healthcare Funds (WIdO), 2001
24. Schulze-Gattermann H. Cost benefit-analysis of Cochlear implantation with children [dissertation] [in German]. Hanover: Medical School of Hanover, 2000
25. Schulze-Gattermann H, Illg A, Schoenermark M, et al. Cost-benefit analysis of pediatric cochlear implantation: German experience. Otol Neurotol 2002 Sep; 23 (5): 674-81
26. Ley S, Quast U. Summary of the most important results of the workshop [in German]. In: Stück B, Vob H, editors. Pneumococcal illnesses of babies and toddlers [in German]. Marburg: Verlag im Kilian, 2001: 83-93
27. Zi Koeln homepage. Available from URL: http: //www.zikoeln.de [Accessed 2003 Jan 30]
28. German Social Court. Judgement in the law case. Reference: B 6 KA 14/98 R from 1999 Aug 25
29. Federal Statistical Office Germany, editor. Health care, Fachserie 12, Reihe 6.2, Diagnostic data of the inpatients [in German]. Wiesbaden: Metzler-Poeschel, 1998
30. Overturf GD and Committee on Infectious Diseases. Prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis [technical report]. Pediatrics 2000; 106 (2): 367-76
31. Federal State Audit Court of Lower Saxony. Message to the Ministry for Women's Issues and Social Affairs of Lower Saxony, Ministry of Education and Arts of Lower Saxony, regional authorities for Central Social Functions: about the cross section check of the regional education centers [in German]. Hildesheim: Selfprint, ed. 1999
32. Schulenburg JM Graf v d, Greiner W, Schöffski O. Recommendations regarding to health-economic evaluation: Hanoverian Consensus [in German]. Zeitschrift für Allgemeinmedizin 1996; 72: 485-90
33. Federal Statistical Office Germany. National accounts: important overall economic sizes and gainful employment [in German]. Wiesbaden, 2000. Available from URL: http://www.destatis.de/basis/d/vgr/vgrtab10.htm and from from URL: http://www.destatis.de/basis/d/erwerb/erwerbtabl.htm [Accessed 2002 Jan 30]
34. Federal Statistical Office Germany. Micro censuses 1998: labour participation of mothers. Approximately 60% of the mothers with children less than 18 years are gainfully employed [in German]. Wiesbaden, 1999. Available from URL: Available from URL: http://www.destatis.de/presse/deutsch/pm1996/p0700031.htm [Accessed 2002 Jan 30]
35. Lazaro A. Theoretical arguments for the discounting of health consequences. Pharmacoeconomics 2002; 20 (14): 943-61
36. Wald ER. Sinusitis in children. N Engl J Med 1992; 326 (5): 319-23
37. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease in the US in 2000: an effect of pneumococcal conjugate vaccine? [abstract]. Centers for Disease Control and Prevention (CDC). Atlanta (GA); 2 Emerging Infections Program, ICAAC 2001, G2041